Latest Blog Posts Tagged "Thought Leadership"
November 14, 2017
The Sherer Report from the Fall/Winter 2017 edition of The Fox Focus, our biannual newsletter.
August 23, 2016
A recent editorial from MJFF and J. William Langston, MD, outlines a strategy to develop targeted treatments that could prevent, slow or stop Parkinson's progression.
July 18, 2016
MJFF's Katie Kopil, PhD, offers her insights on how scientists can pursue non-traditional research careers to help patients.
October 06, 2015
"The road to a cure is not a straight line."
November 18, 2014
Our CEO Todd Sherer, PhD, recently spoke with trade publication The Pink Sheet about progress in Parkinson's disease research and the Foundation's de-risking model.
November 10, 2014
This summer we asked people with Parkinson's to take a survey on the impact of "off" episodes. The results are part of discussions MJFF is leading with groups that make medication coverage decisions.
September 26, 2014
MJFF is working with insurance companies and Medicare/Medicaid to share information on patient needs and payer priorities to help new Parkinson's therapies secure coverage.
September 02, 2014
MJFF CEO Todd Sherer, PhD, and Joseph Jankovic, MD, lay out questions that remain around Parkinson's and areas of research to find answers in a commentary in JAMA Neurology.
August 28, 2014
On a recent visit to our office Chief Scientific Officer Gene Johnson, PhD, sat with us for some perspective on the evolving role of the Foundation and the future of the field.
August 07, 2014
MJFF is working with the FDA to define parameters for clinical trials of drugs to treat mild cognitive impairment with Parkinson's disease or PD-MCI.